Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Previously Marketed

2

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Caspase-3

2

Protein kinase C alpha type

2

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1956

2

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Benign prostatic hyperplasia

2

Breast cancer

2

Cervical cancer

2

Cystic fibrosis

2

Sitosterolemia

2

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

2

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Hoyer

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

1

Mixture

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

2

CHEBI

2

DAILYMED

2

DSLD

2

EPA CompTox

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 2 of 2 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

?-sitosterol

S347WMO6M4

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1956

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Protein kinase C alpha type

Conditions:

Benign prostatic hyperplasia

Cystic fibrosis

Cervical cancer

Beta-sitosterol is one of the main dietary phytosterols found in plants which have a similar skeleton as cholesterol. In human clinical trials, beta-sitosterol has been shown to have cholesterol-lowering effects and to relieve symptoms of benign pro...

static hyperplasia. There has been a large amount of basic research conducted for potential applications of beta-sitosterol in a diverse range of conditions including cervical cancer, breast cancer, cystic fibrosis, and others. Beta-sitosterol is available over the counter as a natural health supplement and is marketed for a wide range of applications including headaches, tuberculosis, allergies, cancers, fibromyalgia, lupus, asthma, hair loss and many others.

SITOSTEROLS

G7V636VTDY

Status:

US Previously Marketed

First approved in 1956

Class:

MIXTURE

Targets:

Protein kinase C alpha type

Conditions:

Benign prostatic hyperplasia

Cystic fibrosis

Cervical cancer

Beta-sitosterol is one of the main dietary phytosterols found in plants which have a similar skeleton as cholesterol. In human clinical trials, beta-sitosterol has been shown to have cholesterol-lowering effects and to relieve symptoms of benign pro...

static hyperplasia. There has been a large amount of basic research conducted for potential applications of beta-sitosterol in a diverse range of conditions including cervical cancer, breast cancer, cystic fibrosis, and others. Beta-sitosterol is available over the counter as a natural health supplement and is marketed for a wide range of applications including headaches, tuberculosis, allergies, cancers, fibromyalgia, lupus, asthma, hair loss and many others.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1